Hefei Lifeon Pharmaceutical Co Ltd
SZSE:003020
Hefei Lifeon Pharmaceutical Co Ltd
SZSE:003020
Price:
24.27
CNY
-2.02%
Market Closed
Market Cap:
¥4.6B
Income Statement
Earnings Waterfall
Hefei Lifeon Pharmaceutical Co Ltd
Hefei Lifeon Pharmaceutical Co Ltd
Income Statement
Hefei Lifeon Pharmaceutical Co Ltd
Hefei Lifeon Pharmaceutical Co Ltd
Currency: CNY
| Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
0
|
1
|
1
|
2
|
0
|
1
|
2
|
1
|
2
|
1
|
0
|
0
|
|
| Revenue |
1 372
N/A
|
1 894
+38%
|
1 991
+5%
|
2 076
+4%
|
2 183
+5%
|
2 273
+4%
|
2 353
+3%
|
2 429
+3%
|
2 503
+3%
|
2 579
+3%
|
2 763
+7%
|
2 618
-5%
|
2 210
-16%
|
1 901
-14%
|
1 423
-25%
|
1 066
-25%
|
1 518
+42%
|
1 109
-27%
|
1 482
+34%
|
1 474
-1%
|
|
| Gross Profit | |||||||||||||||||||||
| Cost of Revenue |
(905)
|
(1 262)
|
(1 280)
|
(1 300)
|
(1 352)
|
(1 369)
|
(1 432)
|
(1 491)
|
(1 551)
|
(1 619)
|
(1 765)
|
(1 608)
|
(1 285)
|
(931)
|
(528)
|
(345)
|
(479)
|
(398)
|
(533)
|
(536)
|
|
| Gross Profit |
466
N/A
|
633
+36%
|
711
+12%
|
776
+9%
|
831
+7%
|
904
+9%
|
920
+2%
|
938
+2%
|
952
+1%
|
960
+1%
|
997
+4%
|
1 010
+1%
|
925
-8%
|
969
+5%
|
895
-8%
|
721
-19%
|
1 040
+44%
|
711
-32%
|
949
+33%
|
938
-1%
|
|
| Operating Income | |||||||||||||||||||||
| Operating Expenses |
(358)
|
(479)
|
(545)
|
(611)
|
(659)
|
(725)
|
(731)
|
(733)
|
(739)
|
(757)
|
(769)
|
(792)
|
(726)
|
(746)
|
(723)
|
(589)
|
(874)
|
(586)
|
(788)
|
(783)
|
|
| Selling, General & Administrative |
(313)
|
(441)
|
(499)
|
(561)
|
(610)
|
(658)
|
(672)
|
(675)
|
(674)
|
(680)
|
(700)
|
(708)
|
(644)
|
(669)
|
(640)
|
(540)
|
(773)
|
(528)
|
(697)
|
(692)
|
|
| Research & Development |
(48)
|
(41)
|
(50)
|
(52)
|
(52)
|
(62)
|
(67)
|
(68)
|
(75)
|
(69)
|
(73)
|
(85)
|
(81)
|
(80)
|
(96)
|
(66)
|
(87)
|
(74)
|
(107)
|
(109)
|
|
| Depreciation & Amortization |
(4)
|
(7)
|
0
|
0
|
0
|
(12)
|
0
|
0
|
0
|
(16)
|
0
|
0
|
0
|
(17)
|
0
|
0
|
(31)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
7
|
10
|
3
|
3
|
5
|
7
|
7
|
10
|
10
|
9
|
5
|
1
|
(1)
|
20
|
13
|
16
|
18
|
18
|
16
|
18
|
|
| Operating Income |
108
N/A
|
154
+43%
|
166
+8%
|
166
0%
|
172
+4%
|
179
+4%
|
189
+5%
|
205
+8%
|
213
+4%
|
204
-4%
|
229
+12%
|
217
-5%
|
199
-8%
|
224
+12%
|
172
-23%
|
132
-23%
|
166
+26%
|
125
-25%
|
161
+29%
|
155
-4%
|
|
| Pre-Tax Income | |||||||||||||||||||||
| Interest Income Expense |
2
|
4
|
5
|
7
|
10
|
13
|
11
|
9
|
36
|
12
|
37
|
58
|
38
|
13
|
35
|
6
|
13
|
9
|
32
|
30
|
|
| Non-Reccuring Items |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
(3)
|
(3)
|
24
|
(3)
|
(0)
|
(0)
|
19
|
0
|
(0)
|
(6)
|
0
|
(2)
|
(2)
|
|
| Total Other Income |
2
|
(0)
|
0
|
3
|
3
|
3
|
3
|
(0)
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
2
|
2
|
3
|
(1)
|
(6)
|
(6)
|
(6)
|
|
| Pre-Tax Income |
111
N/A
|
157
+41%
|
171
+9%
|
175
+3%
|
185
+6%
|
195
+5%
|
202
+4%
|
211
+5%
|
246
+16%
|
240
-2%
|
263
+10%
|
274
+4%
|
236
-14%
|
257
+9%
|
208
-19%
|
140
-33%
|
172
+23%
|
129
-25%
|
186
+44%
|
177
-5%
|
|
| Net Income | |||||||||||||||||||||
| Tax Provision |
(12)
|
(22)
|
(23)
|
(23)
|
(24)
|
(23)
|
(24)
|
(24)
|
(28)
|
(30)
|
(34)
|
(32)
|
(24)
|
(24)
|
(13)
|
(12)
|
(19)
|
(13)
|
(18)
|
(17)
|
|
| Income from Continuing Operations |
99
|
135
|
148
|
153
|
161
|
172
|
178
|
187
|
217
|
210
|
229
|
243
|
212
|
234
|
195
|
128
|
152
|
116
|
168
|
160
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(7)
|
(10)
|
(7)
|
8
|
6
|
5
|
3
|
|
| Net Income (Common) |
99
N/A
|
135
+37%
|
148
+9%
|
153
+3%
|
161
+5%
|
172
+7%
|
178
+3%
|
187
+5%
|
217
+16%
|
210
-4%
|
229
+9%
|
243
+6%
|
210
-13%
|
227
+8%
|
191
-16%
|
127
-33%
|
161
+26%
|
121
-24%
|
173
+43%
|
163
-6%
|
|
| EPS (Diluted) |
1.42
N/A
|
1.94
+37%
|
1.59
-18%
|
1.26
-21%
|
1.33
+6%
|
0.92
-31%
|
1.48
+61%
|
1.56
+5%
|
1.37
-12%
|
1.12
-18%
|
1.43
+28%
|
1.53
+7%
|
1.15
-25%
|
1.18
+3%
|
0.99
-16%
|
0.7
-29%
|
0.84
+20%
|
0.64
-24%
|
0.91
+42%
|
0.88
-3%
|
|
Switch to:
Switch to:
See Also
Discover More
